Search - tctmd.com

Displaying 21 - 40 of 338

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2025

Caitlin E. Cox

May 30, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Yael L. Maxwell

January 13, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Advertisement

TCTMD’s Top 10 Most Popular Stories for May 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

April 2025 Dispatch for the CV Team

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

TCTMD’s Top 10 Most Popular Stories for February 2025

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Top General Cardiology and Prevention News of 2024

Top Structural Heart News of 2024

November 2024 Dispatch for the CV Team

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content